Results 151 to 160 of about 61,558 (234)

Social vulnerability and survival among patients with high-grade glioma treated at a tertiary cancer center. [PDF]

J Neurooncol
Hsi AH, Wathoo C, Campbell E, Nassif M, Buchold GM, Nguyen LH, McNeill LH, Hawk E, Puduvalli VK, Kamiya-Matsuoka C.   +9 more
europepmc   +1 more source

Lactoferrin and Nanotechnology: New Insights Into Glioblastoma Therapy

CNS Neuroscience &Therapeutics, Volume 32, Issue 9, September 2026.
Current glioblastoma multiforme (GBM) management primarily relies on surgery, chemotherapy, and radiotherapy; however, therapeutic efficacy remains limited due to tumor invasiveness and restricted drug penetration across the blood–brain barrier. Lactoferrin (LF), an iron‐binding glycoprotein with receptor‐mediated transport capability, has emerged as a
Atena Abed, Javad Amini Mahabadi
wiley   +1 more source

Recurrent Mandibular Ewing sarcoma in an 11-year-old boy: a rare pediatric case and review of the literature. [PDF]

J Med Case Rep
Nourbakhsh SMK, Shirkhoda M, Jangjoo T.
europepmc   +1 more source

miR‐15a‐5p Regulates Ferroptosis in Glioblastoma by Targeting GLS2

CNS Neuroscience &Therapeutics, Volume 32, Issue 9, September 2026.
Schematic diagram of the mechanism by which miR‐15a‐5p regulates glioblastoma progression through targeting GLS2 and modulating ferroptosis. miR‐15a‐5p regulates the ferroptosis pathway by targeting and inhibiting glutaminase 2 (GLS2) expression: Downregulation of miR‐15a‐5p leads to upregulation of GLS2, which promotes lipid peroxidation, accompanied ...
Yanyan Yu, Helan Yuan, Zikun Fang, Jinyuan Liao, Yancong Yang, Jun Liu, Wenjin Wei, Qiuhua Jiang   +7 more
wiley   +1 more source

Harnessing Repurposed Drugs to Enhance Temozolomide Efficacy in Glioblastoma. [PDF]

Cancer Rep (Hoboken)
Nakhaei A, Taghavi A, Afshari AR, Davoudi F, Gheybi E, Jalili-Nik M.   +5 more
europepmc   +1 more source

Cancer‐related pain: A bidirectional modulator of cancer progression

Clinical and Translational Medicine, Volume 16, Issue 9, September 2026.
CRP and tumour progression engage in a dynamic, bidirectional circuit mediated by multiple mechanisms involving neuroimmunology and cancer ‐neuroscience. Analgesic interventions may affect tumour progression, while anticancer therapies can influence pain. Targeting pain in cancer may have promising therapeutic value in cancer progression.
Junzhe He, Yu Zhang, Qian Liu, Biao Yan, Peiwei Chai, Renbing Jia   +5 more
wiley   +1 more source

Temozolomide reconsidered: Real-World evidence in resistant melanoma cases. [PDF]

Oncologist
Maselli-Schoueri JH, Martinez E, Lagos E, Campos EF, Saldanha EF, Muniz TP, Butler MO, Saibil SD.   +7 more
europepmc   +1 more source

Cinnamaldehyde From Cinnamon as a Food‐Derived Bioactive: Phytochemistry, Anticancer Mechanisms, Bioavailability, Nanoformulation and Safety

Food Frontiers, Volume 7, Issue 5, September 2026.
Cinnamaldehyde derived from Cinnamomum species exerts multitarget anticancer effects by promoting oxidative stress, mitochondrial dysfunction, apoptosis, cell‐cycle arrest, autophagy, and epigenetic changes, and by suppressing mitogen‐activated protein kinase (MAPK), phosphoinositide 3‐kinase/protein kinase B/mechanistic target of rapamycin (PI3K/Akt ...
Gervason Moriasi, Sally Kamau, Gulnaz Seitimova, Shynar Zhumagaliyeva, Javad Sharifi‐Rad, William N. Setzer, Daniela Calina   +6 more
wiley   +1 more source

Erratum: [Corrigendum] Temozolomide abrogates the aggressiveness of urothelial carcinoma cells by enhancing senescence and depleting the side population. [PDF]

Oncol Lett
Kim NY, Hwang SH, Yang Y, Kim Y.
europepmc   +1 more source

Irinotecan plus temozolomide for pediatric relapsed or refractory solid tumors: a retrospective cohort study. [PDF]

Transl Pediatr
Fang J, Zhang Y, Liu Q, Dong Z, Gong H, Zhou W, Wang Y, Liu H.   +7 more
europepmc   +1 more source